Covid-19: Experimental drug remdesivir may have failed in human trial, report shows

Workers in protective suits conduct RNA tests on specimens inside a laboratory at a centre for disease control and prevention, as the country is hit by an outbreak of the novel coronavirus, in Taiyuan, Shanxi province, China - cnsphoto via Reuters

NEW YORK (AFP): The experimental Covid-19 treatment remdesivir has failed in its first randomised clinical trial, inadvertently released results showed Thursday (April 23), dampening expectations for the closely watched drug.

A draft summary went online briefly on the website of the World Health Organisation (WHO) and was first reported by the Financial Times and Stat, which posted a screenshot.